You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cetuximab

Showing 51 - 75 of 558
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Munich (Bevacizumab, Irinotecan, Folinic acid)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Munich, Germany
    Klinikum der Universitaet Muenchen
Dec 2, 2021

Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Sodium Valproate
  • +2 more
  • Saint Leonards, New South Wales, Australia
  • +8 more
Jan 22, 2023

BRAF V600E Negative, KRAS Gene Mutation Negative, Locally Advanced Unresectable Colorectal Adenocarcinoma Trial in United States

Recruiting
  • BRAF V600E Negative
  • +12 more
  • Cetuximab
  • +3 more
  • Scottsdale, Arizona
  • +15 more
Aug 23, 2022

Head and Neck Squamous Cell Carcinoma Trial in France, Germany, Spain (Cisplatin, 5-Fluorouracile, Docetaxel)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Avignon, France
  • +16 more
Aug 22, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston

Recruiting
  • Metastatic Colon Adenocarcinoma
  • +30 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2022

Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (E7050, Cetuximab)

Completed
Has Results
  • Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
  • Tucson, Arizona
  • +22 more
Dec 3, 2021

Head Neck Cancer, Head Cancer, Head Cancer Neck Trial in United States (drug, procedure, radiation)

Recruiting
  • Head and Neck Cancer
  • +5 more
  • Basking Ridge, New Jersey
  • +5 more
Jan 19, 2023

Colorectal Cancer, GIST Trial (DCC-3116, Ripretinib, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • GIST
  • (no location specified)
Jul 14, 2023

Carcinoma, Squamous Cell Trial in Syracuse (drug, biological, radiation)

Completed
  • Carcinoma, Squamous Cell
  • paclitaxel poliglumex
  • +2 more
  • Syracuse, New York
    SUNY Upstate Medical University
Oct 29, 2021

Advanced Colorectal Cancer, Small Intestinal Cancer, Appendiceal Cancer Trial in China (JAB-21822, Cetuximab)

Recruiting
  • Advanced Colorectal Cancer
  • +2 more
  • Beijing, Beijing, China
  • +11 more
Mar 22, 2022

Colorectal Cancer Trial in Nanjing (Raltitrexed, Cetuximab)

Recruiting
  • Colorectal Cancer
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Institute & Hospital
Aug 27, 2021

Colorectal Cancer Trial in Saint-herblain (Oxaliplatin, Folinic Acid, 5-fluoro-uracil)

Completed
  • Colorectal Cancer
  • Saint-herblain, France
    Centre rené Gauducheau
Jan 7, 2022

For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment

Not yet recruiting
  • For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method
  • Shenyang, Liaoning, China
    Liaoning Tumor Hospital & Institute
Mar 7, 2023

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Germany (Cetuximab, FOLFIRI)

Active, not recruiting
  • Adenocarcinoma of the Colon
  • Adenocarcinoma of the Rectum
  • Cetuximab
  • FOLFIRI
  • Bochum, Germany
  • +3 more
Oct 14, 2021

Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7 Trial in United States (biological, drug, other)

Completed
Has Results
  • Colorectal Adenocarcinoma
  • +4 more
  • Bevacizumab
  • +4 more
  • Scottsdale, Arizona
  • +12 more
Jan 27, 2022

Non Small Cell Lung Cancer Trial in France (Afatinib, Cetuximab)

Completed
  • Non Small Cell Lung Cancer
  • Aix-en-Provence, France
  • +32 more
Aug 9, 2022

Metastatic Colorectal Cancer Trial in Madison (Panitumumab, Cetuximab, Irinotecan)

Recruiting
  • Metastatic Colorectal Cancer
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 13, 2022

Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Worldwide (BI 765063, Ezabenlimab, BI 836880)

Recruiting
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • BI 765063
  • +4 more
  • Saint Louis, Missouri
  • +15 more
Aug 10, 2022

Colorectal Cancer Trial in Shanghai (Vemurafenib, Cetuximab)

Recruiting
  • Colorectal Cancer
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Aug 15, 2021

Cancer Colorectal Trial in Levallois-Perret (Cetuximab, Irinotecan)

Recruiting
  • Cancer Colorectal
  • Levallois-Perret, France
    Franco-British Hospital - GCS IHFB Cognacq-Jay
Aug 25, 2021

Squamous Cell Carcinoma of the Head and Neck Trial in Napoli (Valproic Acid, Cisplatin, Cetuximab)

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Valproic Acid
  • +2 more
  • Napoli, Italy
    Istituto Nazionale Tumori Fondazione G. Pascale
Oct 12, 2021

NSCLC Trial in Amsterdam, Groningen, Maastricht (Afatinib, Cetuximab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Amsterdam, North-Holland, Netherlands
  • +3 more
Oct 19, 2021

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Worldwide (NBTXR3, Cetuximab, Radiation Therapy)

Recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Tampa, Florida
  • +17 more
Mar 22, 2022

Head and Neck Squamous Cell Cancer Trial (pembrolizumab, methotrexate, docetaxel)

Completed
Has Results
  • Head and Neck Squamous Cell Cancer
  • pembrolizumab
  • +3 more
  • (no location specified)
Aug 24, 2022

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023